7 assets in Hemorrhagic Disease

Therapeutic assets addressing Hemorrhagic Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Damoctocog Alfa Pegol Hemorrhagic Disease	Bayer	P4	BBB (78)
Warfarin Hemorrhagic Disease	Asan Medical Center	P4	BBB (74)
Alteplase Hemorrhagic Disease	Hamilton Health Sciences Corporation	P4	BB (66)
bay94-9027 Hemorrhagic Disease	Bayer	P3	BB (64)
Apixaban Hemorrhagic Disease	Region Stockholm	P3	B (60)
Tranexamic Acid Hemorrhagic Disease	Northwestern University	P3	B (60)
Oricar-017 Hemorrhagic Disease	OriCell Therapeutics Co., Ltd.	P1	CC (43)